Targeting cancer cells selectively via resonant harmonic excitation
US11097130B2 · kind B2 · utility
0Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2016 |
| Grant date | Aug 24, 2021 |
| Priority date | — |
| Expiry date | Oct 4, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2007/0004
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Systems and methods for targeting specific cell types by selective application of ultrasonic harmonic excitation at their resonance frequency (“oncotripsy”) are presented. The systems and methods result in the lysis of targeted cell types by using ultrasonic harmonic excitations that have been specifically tuned to disrupt the nuclear membrane of the targeted cells types by inducing a destructive vibrational response therein while leaving non-targeted cell types intact. The target cells types may be cancerous cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.